Alan Scott Ente. (539115)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue has grown modestly at 5.76%, showing some continued business activity.
• Latest quarter sales of ₹8 crore indicate the company is still operating, not dormant.
• Book value is positive at ₹11.03 per share, providing a small equity cushion.
• Low market cap of ₹24 crore means even modest improvement could have an outsized effect, though this is speculative.

Concerns

• Latest quarter net loss of ₹1 crore and profit growth of -212.90% show clear earnings deterioration.
• ROCE of -14.21% and ROE of -0.65% indicate capital is being destroyed, not compounded.
• P/B of 5.96 is extremely expensive for a business with negative returns and no dividend.
• Piotroski F-Score of 3/9 signals weak financial health; the 52-week range inconsistency also raises data reliability questions.

AI Analysis

I approach a stock the way I approach a business. Alan Scott Ente. fails almost every test I would apply. It is a microcap film production, distribution and exhibition company with a market capitalization of ₹24 crore and a price of ₹65.77. The first warning is the 52-week range of ₹199.25–₹404.00. The current price sits far below the lower end. Either the data is unreliable or there has been a corporate action; in both cases, Graham would say: define what you know before you invest. Sales grew 5.76%, but that is meaningless when profit growth is -212.90%. The latest quarter had sales of ₹8 crore and a net loss of ₹1 crore. A negative P/E tells me there are no earnings to justify the price. The balance sheet is also not working: return on capital employed is -14.21%, and return on equity is -0.65%. Yet the stock trades at 5.96 times book value. For a business that is destroying value, paying nearly six times book is speculation, not investment. Film production is a hit-driven business with no durable moat, no pricing power, and unpredictable cash flows. There is no dividend, promoter holding is not available, and debt/equity is not available—so I cannot judge leverage or alignment. The Piotroski F-score of 3/9 adds to the picture of weak financial health. This might be a cyclical operation that someday recovers with a successful film, but there is no evidence of a turnaround. I do not see a margin of safety. I would rather pass on the chance of a film's success than risk permanent loss. In the cinema of markets, this looks like a trailer for trouble, not a long-term holding.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer